The Effectiveness and Safety of Fenofibrate and Saroglitazar in the Treatment of Diabetic Dyslipidemia. Life and Science, [S. l.], v. 5, n. 2, p. 07, 2024. DOI: 10.37185/LnS.1.1.632. Disponível em: https://lifenscience.org/index.php/life-and-science/article/view/632. Acesso em: 17 oct. 2026.